← Evidence map

ArticleToxicology reports2025

Corrigendum to: "Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells" [Toxicol. Rep. Volume 13, December 2024, 101765].

Hossein Majidzadeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Corrigendum to: "Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells" [Toxicol. Rep. Volume 13, December 2024, 101765]. | Socratic